GLP-1 medication supply constraints have left many patients grappling with the challenge of accessing these highly sought-after drugs. Ro CEO Zach Reitano...
Ro CEO Zach Reitano joins Asking for a Trend to shed light on how his company aims to make supply information more readily available to patients in need.
So again, it's that doctor's office, lab and pharmacy all through the lens of helping a patient achieve their goals. Uh the, the U si think this is actually a one of one situation um when it comes to health care and, and the invention of a new, a new drug, a lot of people are drawing different sort of historical analogies to either blood pressure medication or statins.
And the second thing it does is it automatically notifies the FDA if, if the patient wants about their experience with the shortage in real time to make sure that the agency has as much information about real life, real time patient experiences as as possible.So we built it, we've seen tremendous traction.
'I am trying to survive': Kate Beckinsale breaks her silence on 6-week hospitalization. What is a Mallory-Weiss tear?Starting menstruation is an important sign of health. A new study shows that the trend of children starting at an earlier age may point to worrying conditions.
Healthcare Landscape Ro Patients Healthcare Providers
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vitamin Shoppe enters GLP-1 race with telehealth service: CEOVitamin Shoppe has entered the telehealth services sector by offering a GLP-1 program, partnering with WellSync to provide the service. The Vitamin Shoppe...
Read more »
Hecla CEO Phillips Baker retires, interim CEO appointedThe Kitco News Team brings you the latest news, videos, analysis and opinions regarding Precious Metals, Crypto, Mining, World Markets and Global Economy.
Read more »
Gildan CEO, board resign ahead of shareholder vote, paving way for ex-CEO's returnThe CEO and board of directors at Gildan Activewear Inc. have resigned ahead of the company's annual meeting on Tuesday, paving the way for the company's co-...
Read more »
Gildan CEO, board resign ahead of shareholder vote, paving way for ex-CEO's returnThe CEO and board of directors at Gildan Activewear Inc. have resigned ahead of the company's annual meeting on Tuesday, paving the way for the company's co-founder to return as chief executive.
Read more »
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on WegovyNovo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
Read more »
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetesExplore stories from Atlantic Canada.
Read more »